You are currently viewing Everolimus vs sirilmus eluting stents for bifurcation

Everolimus vs sirilmus eluting stents for bifurcation

Everolimus vs sirilmus eluting stents for bifurcation

European Bifurcation Club 2011, EBC 2011 – Lisbon, Portugal

HOT NEWS SESSION

Everolimus vs sirilmus eluting stents for bifurcation

Author: Manuel Pan, MD, Reina Sofia Hospital, Sevilla, Spain

 

BACKGROUND

  • Simple approach or provisional SB stenting is the current preferred strategy for the percutaneous treatment of bifurcation lesions.
  • The outcome of patients treated with this strategy may be influenced by the type of drug eluting stent implanted at main vessel.
  • The metal platform of the stent is deformed when SB is dilated; the polymer may be damaged; and the drug may be unevenly distributed.

AIM

To compare the efficacy of sirolimus- and everolimus-eluting stents in patients with bifurcation lesions treated by provisional side branch stenting.

CONCLUSION

In patients with bifurcation lesions, no significant differences in clinical outcome at 1-year follow-up were observed between sirolimus and everolimus-eluting stent groups.

 

Download here

Leave a Reply